Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Ladhani,
Open-Label, Randomised, Parallel-Group, Multicentre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B/oil-in-water Emulsion-Adjuvanted (AS03B) Split-Virion Versus Non-Adjuvanted Whole-Virion H1N1 Influenza Vaccine in UK Children 6 Months to 12 Years of Age
Health Technology Assessment
Medicine
Health Policy
Related publications
Safety of AS03-adjuvanted Split-Virion H1N1 (2009) Pandemic Influenza Vaccine: A Prospective Cohort Study
BMJ Open
Medicine
Influenza a/H1n1 MF59 Adjuvanted Vaccine in Pregnant Women and Adverse Perinatal Outcomes: Multicentre Study
British Medical Journal
Medicine
Influenza Vaccination in Children Primed With MF59®-adjuvanted or Non-Adjuvanted Seasonal Influenza Vaccine
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
The Responses of Aboriginal Canadians to Adjuvanted Pandemic (H1N1) 2009 Influenza Vaccine
CMAJ
Medicine
Humoral and Cellular Responses to a Non-Adjuvanted Monovalent H1N1 Pandemic Influenza Vaccine in Hospital Employees
BMC Infectious Diseases
Infectious Diseases
MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine: Pooled Analysis of Safety in Older Adults ≥65 Years of Age
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Peripartum Outcomes: Non-Adjuvanted v. Adjuvanted H1N1 Vaccination
CMAJ
Medicine
Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
A Phase 2/3 Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split-Virion Influenza Vaccine (IVACFLU-S) in Healthy Adults in Vietnam
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
